Study
Review All
Quiz!
|
digoxin |
0.5 - 2 ng/ml |
|
theoplyline |
10-20 mcg/ml |
|
coumadin (warfarin) INR |
2-3 |
|
lithium |
1-1.5 mEq/L in acute mania |
|
lithium toxicity early symptoms |
N/V, fine tremors, diarrhea |
|
lithium severe toxicity symptoms |
Ataxia, confusion, seizures |
|
chlorpromazine hydrochloride (Thorazine) |
SE:EPS, akathisia (motor restlessness); dystonias (protrussion of the tongue, abnormal posturing);pseudoparkinsonism (tremors, rigidity); dyskinesia (stiff neck, difficulty swallowing) ANTIDOTE: CONGENTIN (ANTIPARKINSONISM MED) |
|
NSAIDS |
SE:Fluid retention, dizziness, GI distress, pruritus, rash |
|
Blood transfussion: |
Hemolitic reaction: Hypotension, chills, back pain Allergic: urticaria (hives), wheezing, facial flushing, epiglotal edema |
|
Dantrolene (Dantrium) |
acts directly on skeletal muscle to relieve muscle spasticity. The primary action is the suppression of calcium release from the sarcoplasmic reticulum. This in turn decreases the ability of the skeletal muscle to contract. |
|
diazepam (Valium) |
SE: Incoordination and drowsiness |
|
benztropine mesylate (Congentin) |
decreased tolerance to heat as a result of diminished ability to sweat and should plan rest periods in cool places during the day. The client also is instructed to avoid driving or operating hazardous equipment if drowsy or dizzy. The client should be instructed to stop taking the medication if difficulty swallowing or speaking develops or if vomiting occurs; to inform the physician if central nervous system effects occur; and to monitor urinary output and watch for signs of constipation. |
|
magnesium level is 1.6 to 2.6 mg/dL Hypermagnesemia: |
neurological depression, drowsiness and lethargy, loss of deep tendon reflexes, respiratory insufficiency, bradycardia, and hypotension. |
|
Hypomagnesemia: |
Trousseau’s sign |
|
fluvoxamine (Luvox) |
f |
|
Lithium blood levels |
every 3 to 4 months. |
